Watchlist Price Alert

AcelRx Pharmaceuticals In... (ACRX)

NASDAQ: ACRX · Real-Time Price · USD

0.86

0.06 (7.50%)

At close: Jan 09, 2024, 9:00 PM

AcelRx Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	5.72M	15.28M	12.66M	27.27M	14.68M	87.97M	52.9M	80.31M
Short-Term Investments	3.66M	495K	38.97M	15.61M	51.45M	17.74M	7.57M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	8.84M	246K	2.17M	656K	1.19M	1.06M	1.09M	228K
Receivables	n/a	309K	160K	635K	520K	401K	1.53M	5.83M
Inventory	n/a	1.18M	1.11M	1.63M	3.29M	854K	956K	2.15M
Other Current Assets	2.17M	2.31M	2.59M	1.68M	1.74M	1.02M	455K	756K
Total Current Assets	11.56M	24.57M	55.49M	46.83M	71.69M	107.99M	63.41M	89.05M
Property-Plant & Equipment	n/a	13.86M	20.23M	18.81M	18.48M	11.48M	11.05M	10.71M
Goodwill & Intangibles	n/a	8.82M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.84M	22.92M	22.4M	19.46M	19.67M	12.54M	12.14M	10.94M
Total Assets	20.39M	47.49M	77.89M	66.3M	91.36M	120.53M	75.55M	99.99M
Account Payables	1.34M	2.04M	2.12M	2.74M	1.72M	2.07M	1.42M	1.56M
Deferred Revenue	n/a	115K	86K	49K	411K	315K	362K	362K
Short-Term Debt	n/a	7.46M	9.86M	9.85M	5.6M	8.61M	7.73M	2.91M
Other Current Liabilities	3.18M	4.15M	6.44M	5M	5.88M	4.93M	4.15M	5.36M
Total Current Liabilities	4.51M	13.77M	18.51M	17.64M	13.61M	15.93M	13.66M	10.19M
Long-Term Debt	n/a	2.96M	8.76M	15.75M	24.16M	3.38M	11.37M	18.64M
Other Long-Term Liabilities	1.78M	7.91M	81K	88.66M	490K	93.29M	82.98M	72.22M
Total Long-Term Liabilities	1.78M	11.9M	95.28M	104.41M	119.16M	100.35M	98.4M	95.14M
Total Liabilities	6.29M	25.67M	113.79M	122.05M	132.77M	116.28M	112.06M	105.33M
Total Debt	n/a	10.42M	18.62M	25.6M	29.76M	11.99M	19.1M	21.55M
Common Stock	17K	8K	137K	98K	79K	78K	51K	45K
Retained Earnings	-444.23M	-425.83M	-473.58M	-438.49M	-398.11M	-345.02M	-297.87M	-246.36M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-8.94M	-8.44M	3K
Shareholders Equity	14.11M	21.81M	-35.89M	-55.75M	-41.42M	4.25M	-36.51M	-5.34M
Total Investments	3.66M	495K	38.97M	15.61M	51.45M	17.74M	7.57M	n/a